Brivaracetam is the generic ingredient in two branded drugs marketed by Ucb Inc, Aurobindo Pharma Ltd, Lupin Ltd, Sunshine, and Zydus Pharms and, and is included in seven NDAs. There are two patents protecting this compound.
Drug patent litigation for BRIVARACETAM.
This ingredient has one hundred and sixty-two patent family members in forty-five countries.
One supplier is listed for this compound. There are five tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com